A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma

Attal, Michel; Harousseau, Jean-Luc; Stoppa, Anne-Marie; Sotto, Jean-Jacques; Fuzibet, Jean-Gabriel; Rossi, Jean‐François; Casassus, Philippe; Maisonneuve, Hervé; Façon, Thierry; Ifrah, Norbert; Payen, Catherine; Bataille, Régis

doi:10.1056/nejm199607113350204

Public

A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma

Published in New England Journal of Medicine • Jul 11, 1996

Authors:

Michel Attal

Jean-Luc Harousseau

Anne-Marie Stoppa

Abstract

BACKGROUND: The median survival of patients with myeloma after conventional chemotherapy is three years or less. Promising results have been reported with high-dose therapy supported by autologous bone marrow transplantation. We conducted a randomized study comparing conventional chemotherapy and hi...

Subject

Medicine

Multiple myeloma

Chemotherapy

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!